AIB
BMY icon

Allied Irish Banks’s Bristol-Myers Squibb BMY Stock Holding History

Allied Irish Banks’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$47K Hold
1,036
– – 4.17% 13
2013
Q2 		$46K Buy
+1,036
New +$45K 3.85% 13

Other funds holding BMY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Allied Irish Banks's BMY Position: Q3 2013 in Review

Allied Irish Banks held its Bristol-Myers Squibb (BMY) position steady in Q3 2013 at 1,036 shares worth $47K. The position accounts for 4.17% of the portfolio, ranked #13.

Allied Irish Banks first reported a position in BMY in Q2 2013 and has held it in 2 quarters since. 1,188 funds tracked by Wall St. Rank hold BMY as of Q3 2013.

  • Allied Irish Banks held 1,036 shares of Bristol-Myers Squibb worth $47K as of Q3 2013.
  • Allied Irish Banks left its Bristol-Myers Squibb share count unchanged in Q3 2013.
  • Bristol-Myers Squibb made up 4.17% of Allied Irish Banks's portfolio in Q3 2013, its #13 holding.
  • Allied Irish Banks first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 2 quarters since.
  • 1,188 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2013.

Based on Allied Irish Banks's 13F filing for Q3 2013, filed 14 Nov 2013.